Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,640 across all filing types
Latest filing 2026-04-06 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
4 Statement of changes in beneficial ownership 2 pages 12.2KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which reports changes in beneficial ownership of company securities by insiders such as directors or officers. It details a transaction by Peter C. Farrell, a director of ResMed Inc., involving the disposal of shares. Form 4 is specifically used for reporting insider transactions and is not a financial report, earnings release, or other types of filings. Therefore, this document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not an announcement or certification.
2026-04-06 English
Statement of CDIs on issue - RMD 3 pages 12.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly statements of securities issued, net differences, and reasons for changes such as transfers, stock options, employee stock purchase plans, and share repurchases. The document is relatively short (3043 characters) and is a regulatory announcement related to securities issued and changes in share capital structure. It does not contain financial statements, management discussion, or detailed financial results. It is not an annual or interim report, earnings release, or audit report. The content aligns with a Share Issue/Capital Change announcement, as it reports on changes in issued securities and related capital movements.
2026-04-06 English
4 Statement of changes in beneficial ownership 2 pages 12.2KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which reports changes in beneficial ownership of company securities by insiders such as officers or directors. It includes detailed information about transactions in the company's stock by Brett Sandercock, the Chief Financial Officer of ResMed Inc. Form 4 is specifically used to disclose insider trading activities and is not a financial report, earnings release, or any other type of corporate filing listed. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length and content confirm it is a full Form 4 filing, not just an announcement or certification.
2026-04-06 English
Resmed to Report Third Quarter Fiscal 2026 Results 1
Earnings Release Classification · 95% confidence The document is a short announcement from Resmed about the upcoming release of their third quarter fiscal 2026 earnings report and a webcast to discuss the results. It does not contain actual financial data or detailed financial statements but rather informs investors about the date and time of the earnings release and webcast. The document length is only 2116 characters, which is quite short and consistent with an earnings release announcement rather than the full earnings report or transcript. Therefore, this document is best classified as an Earnings Release (ER) announcement.
2026-04-01 English
Change in substantial holding 2 pages 13.4KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors and officers. The text includes detailed tables of securities acquired and disposed of by Michael J. Farrell, Chairman and CEO of ResMed Inc., including dates, transaction codes, and prices. This type of filing is specifically related to insider transactions and personal share dealings by company executives. It is not an annual report, earnings release, or any other type of financial or corporate report. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content fully support this classification with high confidence.
2026-03-15 English
144 Report of proposed sale of securities 2 pages 146.5KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details insider sales of shares by an officer/director of the issuer, including number of shares, dates, and broker information. This type of filing is specifically used to report personal share transactions by company insiders. It is not an earnings release, annual report, or any other financial report. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 4411 characters, which is consistent with a detailed insider transaction report rather than a brief announcement or a full financial report.
2026-03-10 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.